A Japanese conglomerate has found that the anti-parasitic drug ivermectin is effective and safe for the treatment of the COVID-19 Omicron variant, according to a phase III clinical trial. Kowa Co. Ltd.
ORIGINAL LINK
“Those who are able to see beyond the shadows and lies of their culture will never be understood, let alone believed, by the masses.” - Plato
Seeking Truth in a World of Propaganda. Links do not necessarily indicate agreement with stories or perspectives.